Cardio Diagnostics Holdings Inc (CDIOW) is a pioneering entity in the medical technology sector, dedicated to revolutionizing cardiovascular care through cutting-edge diagnostic solutions. The company leverages proprietary algorithms and advanced genetic testing to improve the precision of cardiovascular risk assessments, facilitating personalized management strategies for patients. With a robust focus on data analytics and genomics, Cardio Diagnostics is strategically poised to harness the escalating demand for precision medicine, which promises not only enhanced clinical outcomes but also substantial growth opportunities within the dynamic healthcare market.
| Revenue (TTM) | 16,560 |
| Gross Profit (TTM) | 16,560 |
| EBITDA | $-6.27M |
| Operating Margin | -66598.00% |
| Return on Equity | -65.60% |
| Return on Assets | -38.00% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $3.01 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 185.10% |
| Shares Outstanding | 0 |
| Float | $2.83M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CDIOW and any ticker you trade — then tracks every position and per-strategy win rate.